US Stock MarketDetailed Quotes

ACET Adicet Bio

Watchlist
  • 0.900
  • -0.014-1.53%
Close Nov 22 16:00 ET
  • 0.910
  • +0.010+1.11%
Post 19:59 ET
74.16MMarket Cap-529P/E (TTM)

About Adicet Bio Company

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Company Profile

SymbolACET
Company NameAdicet Bio
Listing DateJan 26, 2018
Issue Price15.00
Founded2014
CEOMr. Chen Schor, M.B.A.
MarketNASDAQ
Employees143
Fiscal Year Ends12-31
Address131 Dartmouth Street,3rd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02116
Phone1-650-503-9095
Websitehttp://www.adicetbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Chen Schor, M.B.A.
  • Chief Executive Officer, President and Director
  • 3.99M
  • Nick Harvey
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Blake Aftab, PhD
  • Chief Scientific Officer
  • 2.48M
  • Dr. Donald Healey, PhD
  • Chief Technology Officer
  • --
  • Dr. Francesco Galimi, M.D.,PhD
  • Chief Medical Officer
  • 1.99M
  • Dr. Andrew Sinclair, PhD
  • Independent Director
  • 194.37K
  • Steve Dubin, J.D.
  • Independent Director
  • 197.87K
  • Dr. Jeffrey A. Chodakewitz, M.D.
  • Independent Director
  • 183.87K
  • Dr. Lloyd Klickstein, M.D.,PhD
  • Independent Director
  • --
  • Dr. Aya Jakobovits, PhD
  • Independent Director
  • 183.87K
  • Katie Peng
  • Independent Director
  • --
  • Dr. Carl L. Gordon, C.F.A.,PhD
  • Independent Director
  • 218.87K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data